forum

CAPLIPOINT Share Price Discussion

Caplin Point Laboratories Ltd.
Sector: Pharmaceuticals and health care
... Read more
CAPLIPOINT Share Price *
424.5 -10.95 (-2.51%)
* (quote may be delayed)

CAPLIPOINT Discussion Forum

Time to buy ‘fear’? Top 10 stocks based on Warren Buffett investment methodology
Although market gurus have time and again said that the best time to buy is when there is fear on the street, it is a difficult strategy to implement.
moneycontrol.com
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share

CAPLIPOINT - chart - 241741
Caplinpoint
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share

Caplinpoint
CAPLIPOINT - chart - 208305
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
  • CAPLIPOINT - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization3,043.78
    Enterprise Value2,998.93
    Price to Earnings42.47
    Price to Book Value7.05
    Return on Capital Employed0.5
    Return on Equity0.35
    Face Value2
    Dividend YieldNA
  • CAPLIPOINT Share Price - Technicals

    keyboard_arrow_down
    CAPLIPOINT - 52 Week High₹519
    CAPLIPOINT - 52 Week Low₹296.05
  • CAPLIPOINT Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 16433437.8424426.8
    Sep 13448.35448.35432435.45
    Sep 12432.9447432.9442
    Sep 11428449.8421.1436.05
    Sep 9420426.7416421.1
  • CAPLIPOINT Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹422.02
    30 Day Moving Average₹421.23
    50 Day Moving Average₹419.14
    100 Day Moving Average₹406.27
    200 Day Moving Average₹395.62
  • CAPLIPOINT - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue427344.360.24
    Operating Profit14397.60.47
    Profit Before Tax14693.410.56
    Net Income10270.860.44
  • CAPLIPOINT - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds4322950.46
    Total Liabilities107116-0.08
    Total Assets5394110.31
  • CAPLIPOINT - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity2155.71-0.62
    Cash from Investing Activity-58-37.070.56
    Cash from Financing Activity-12-6.740.78
    Net Cash Flow-4911.89-5.12
  • CAPLIPOINT - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.250.22
    Return on Equity0.350.36
    Return on Capital Employed0.50.48
  • CAPLIPOINT - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.78
    3 Year CAGR Growth in Operating Profit1.5
    3 Year CAGR Growth in EBIDTA1.77
    3 Year CAGR Growth in Net Income1.49
    3 Yr CAGR Growth - Diluted EPS-0.5
  • CAPLIPOINT - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue2.48
    5 Year CAGR Growth in Operating Profit5.51
    5 Year CAGR Growth in EBIDTA6
    5 Year CAGR Growth in Net Income6.13
    3 Yr CAGR Growth - Diluted EPS0.42
  • CAPLIPOINT Share Price - Recent News

    keyboard_arrow_down
    NewsBot
    Aug 5 4:48 PM
    Time to buy ‘fear’? Top 10 stocks based on Warren Buffett investment methodology
    moneycontrol.com
    NewsBot
    Jul 25 10:28 PM
    NewsBot
    Jul 25 5:33 PM
    NewsBot
    Jul 18 7:18 PM
    NewsBot
    Jun 17 6:13 PM
    NewsBot
    Jun 14 7:13 PM
    NewsBot
    Jun 14 4:18 PM
    NewsBot
    May 22 8:33 PM
    NewsBot
    May 22 8:33 PM
    NewsBot
    Apr 8 5:13 PM
  • CAPLIPOINT - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.